Canopy Growth Corporation Stock

Equities

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. 16:18:04 2024-05-17 EDT 5-day change 1st Jan Change
14.81 CAD -1.07% Intraday chart for Canopy Growth Corporation +19.82% +119.08%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 321M 236M Sales 2025 * 303M 222M Capitalization 1.11B 816M
Net income 2024 * -491M -360M Net income 2025 * -121M -88.84M EV / Sales 2024 * 4.8 x
Net Debt 2024 * 427M 314M Net Debt 2025 * 403M 296M EV / Sales 2025 * 5.01 x
P/E ratio 2024 *
-2.53 x
P/E ratio 2025 *
-12 x
Employees 1,621
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.07%
1 week+19.82%
Current month-27.58%
1 month+66.22%
3 months+187.57%
6 months+92.34%
Current year+119.08%
More quotes
1 week
12.28
Extreme 12.28
16.27
1 month
10.32
Extreme 10.32
20.50
Current year
3.74
Extreme 3.74
20.50
1 year
3.74
Extreme 3.74
26.00
3 years
3.74
Extreme 3.74
326.00
5 years
3.74
Extreme 3.74
716.00
10 years
3.74
Extreme 3.74
766.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 18-10-31
Director of Finance/CFO 52 19-12-01
Investor Relations Contact - 15-12-31
Members of the board TitleAgeSince
Chief Executive Officer 60 18-10-31
Chairman 69 20-03-30
Director/Board Member 67 20-03-30
More insiders
Date Price Change Volume
24-05-17 14.81 -1.07% 4,071,279
24-05-16 14.97 +11.22% 9,117,360
24-05-15 13.46 +1.36% 2,801,739
24-05-14 13.28 +3.51% 4,339,303
24-05-13 12.83 +3.80% 2,817,064

Delayed Quote Toronto S.E., May 17, 2024 at 04:18 pm

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
14.81 CAD
Average target price
7.808 CAD
Spread / Average Target
-47.28%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW